Top Mallinckrodt drug faces scrutiny after analyst report, whistleblower suit

Mallinckrodt has seen its share price hit 52-week lows in recent weeks amid heightened scrutiny of Acthar.

Read more

Have you heard?

Missouri Business Alert is participating in CoMoGives2019!

Find out how we plan to use your gift to enhance training and programming for our students